Inside the delicate chambers of the human eye, a nightmare can unfold in days: bacterial endophthalmitis, a rare but devastating infection that threatens sight faster than most patients—or even their doctors—can respond. Researchers at the University of Utah's John A. Moran Eye Center have now identified which bacterial culprits pose the greatest danger, a discovery that could reshape how ophthalmologists treat this vision-threatening emergency.
Eye surgery is remarkably safe today, yet this complication still haunts operating rooms. When endophthalmitis strikes, the stakes are immediate and personal. A patient's ability to read, drive, or recognize a loved's face can hang on whether their doctor recognizes the specific bacteria causing the infection in time. Yet for decades, treatment decisions have rested largely on a single measure: how much vision the patient had already lost at the moment of diagnosis. That narrow lens may soon need to widen.
Christopher Conrady and his colleagues at the Moran Eye Center—including fellow researchers Akbar Shakoor and Albert T. Vitale—analyzed more than 240 cases of endophthalmitis treated between 2012 and 2022 across four academic medical centers. Their analysis, published in the American Journal of Ophthalmology, revealed something clinically crucial: not all bacteria behave the same way inside the eye. Some triggered relatively mild disease; others unleashed rapid, devastating damage within days.
The most aggressive culprits were certain Streptococcus and Enterococcus species, which sent patients spiraling toward severe vision loss and serious complications far more often than the more common surface bacteria typically suspected in eye infections. These pathogenic outliers demanded speed and precision in treatment—yet the diagnostic tools available to ophthalmologists often couldn't identify them fast enough. That gap between knowing an infection was present and knowing exactly which organism was causing it could mean the difference between recovery and permanent blindness.
"Not all infections behave the same way," Conrady said in explaining the research. "Our findings suggest we may need to identify the most dangerous infections faster so we can intervene earlier and better protect patients' vision." The work points toward a future where treatment decisions reflect not just visual acuity at diagnosis, but also the organism itself—information that could guide decisions about antibiotic injections or whether a patient needs emergency surgery to clear the infection.
The findings have exposed a deeper problem. Endophthalmitis care has remained largely tethered to a landmark study published in 1996, nearly three decades ago. In a newly published editorial in Ophthalmology journal, Conrady argues for faster diagnostic tools and additional studies to understand which treatments work best for different bacterial types. He frames this not as abandoning proven approaches, but as giving patients the best possible chance.
"This is about making excellent care even better," Conrady said. For patients facing the sudden terror of a post-surgical eye infection, that commitment to precision—to knowing not just that something is wrong, but exactly what it is and how dangerous it might be—could be the difference that preserves the world in their eyes.